ID: ALA3427350

Max Phase: Preclinical

Molecular Formula: C21H21N3

Molecular Weight: 315.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C(=N/N1CCN(c2ccccc2)CC1)\c1ccc2ccccc2c1

Standard InChI:  InChI=1S/C21H21N3/c1-2-8-21(9-3-1)23-12-14-24(15-13-23)22-17-18-10-11-19-6-4-5-7-20(19)16-18/h1-11,16-17H,12-15H2/b22-17+

Standard InChI Key:  NLGUQCOPOLRZLS-OQKWZONESA-N

Associated Targets(non-human)

Patatin-like phospholipase domain-containing protein 2 302 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 315.42Molecular Weight (Monoisotopic): 315.1735AlogP: 4.00#Rotatable Bonds: 3
Polar Surface Area: 18.84Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.24CX LogP: 4.30CX LogD: 4.30
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.68Np Likeness Score: -1.20

References

1. Mayer N, Schweiger M, Melcher MC, Fledelius C, Zechner R, Zimmermann R, Breinbauer R..  (2015)  Structure-activity studies in the development of a hydrazone based inhibitor of adipose-triglyceride lipase (ATGL).,  23  (12): [PMID:25778769] [10.1016/j.bmc.2015.02.051]

Source